Rett syndrome (RTT) is an X-linked neurodevelopmental disorder linked to motor system dysfunction as well as loss of communication skills and cognitive deficits. The mutation in the X-linked gene, encoding for methyl- CpG binding protein 2 (MeCP2), accounts for over 80% of RTT cases. Mutant MeCP2 mice exhibit phenotypic characteristics similar to those in RTT patients, i.e. impairment of synaptic function and plasticity. Recent data generated in our laboratory demonstrate that T cells can regulate synaptogenesis mediated through control of astrocyte function. Depletion of T cells correlates with reduced synaptogenesis and impaired cognition, whereas boost of immune responses following vaccination with a synthetic copolymer (Cop-1) improves cognitive performance. Our major hypothesis is that the malfunctioning immune system in RTT patients and MeCP2tmHzo/MeCP2+ mice contributes to disease pathogenesis and that a boost in immune response may impede disease progression. First, we aim to characterize the adaptive and innate immune function in MeCP2tmHzo/MeCP2+ mice. We will assess the immune system during disease development by addressing the function of innate and adaptive immunity.
Our second aim addresses the role of immunity in RTT onset and progression. We expect that depletion of T cells from MeCP2tmHzo/MeCP2+ mice will exacerbate disease, whereas exchange or boost of the existing immune system will ameliorate disease symptoms and increase longevity. Mice will be analyzed based on neuroanatomical examinations of synaptic puncta, cognitive performance, and life span as well as observations of motor and social behavior.

Public Health Relevance

Rett syndrome (RTT) is an X-linked neurodevelopmental disorder linked to motor system dysfunction as well as loss of communication skills and cognitive deficits. Recent data generated in our laboratory demonstrate that T cells can regulate synaptic plasticity and cognition. In this proposal we will develop our hypothesis that the malfunctioning immune system in RTT patients and MeCP2tmHzo/MeCP2+ mice contributes to disease pathogenesis and thus boost of immune response using vaccine approach may slow down disease progression.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21HD056293-02
Application #
7752860
Study Section
Developmental Brain Disorders Study Section (DBD)
Program Officer
Oster-Granite, Mary Lou
Project Start
2009-01-01
Project End
2010-12-31
Budget Start
2010-01-01
Budget End
2010-12-31
Support Year
2
Fiscal Year
2010
Total Cost
$187,481
Indirect Cost
Name
University of Virginia
Department
Neurosciences
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Derecki, Noël C; Cronk, James C; Lu, Zhenjie et al. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484:105-9
Derecki, Noel C; Cardani, Amber N; Yang, Chun Hui et al. (2010) Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207:1067-80
Lu, Zhenjie; Kipnis, Jonathan (2010) Thrombospondin 1--a key astrocyte-derived neurogenic factor. FASEB J 24:1925-34
Derecki, N C; Privman, E; Kipnis, J (2010) Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction? Mol Psychiatry 15:355-63